Markets Gone Wild

The Potential Claims Investigation on Fulcrum Therapeutics, Inc. Investigation Details New York, NY / ACCESSWIRE / September 20, 2024 / Bronstein, Gewirtz & Grossman, LLC is conducting an investigation on behalf of purchasers of Fulcrum Therapeutics, Inc. (“Fulcrum” or “the Company”) (NASDAQ:FULC). Investors who have bought Fulcrum securities are encouraged to gather more information and…

Important Deadline for INDV Investors Approaching Don’t Miss Your Chance to Recover Losses MONSEY, N.Y., Sept. 20, 2024 (GLOBE NEWSWIRE) — The law firm of Wohl & Fruchter LLP has issued a reminder to Indivior (“INDV”) investors regarding the upcoming deadline of October 1, 2024. This deadline marks the last opportunity for investors to submit…

Watch Out Wall Street, U.S. Global Investors is Making Moves! By Investment Guru Extraordinaire September 20, 2024 Well folks, hold onto your hats because U.S. Global Investors, Inc. is shaking things up with a major update to their stock repurchase program. This registered investment advisory firm, known for its expertise in global markets and specialized…

Welcome to the VinFast Show: A Look Into the Electric Vehicle Market Unpacking VinFast’s Success in the Electric Vehicle Space When it comes to electric vehicles, VinFast is making waves in the industry. The Vietnamese company, a subsidiary of Vingroup JSC, has reported impressive growth in the second quarter of 2024. With a 44% increase…

Mullen Technical and Sales Team in Dubai for Delivery of First EV Vehicles Mullen Automotive and VoltiE Group Collaboration This week, the Mullen technical and sales team are in Dubai to deliver the first batch of electric vehicles (EVs) to Volt Mobility, a leading vehicle transport and leasing company in the GCC region. This exciting…

Celebrating a Milestone: Zolbetuximab Approved in the EU for Gastric Cancer Treatment The Breakthrough Therapy Imagine a world where advanced gastric cancer can be treated effectively with a targeted therapy. That world is now a reality with the approval of zolbetuximab in the European Union. This groundbreaking therapy targets claudin 18.2, a biomarker expressed in…

Delivering Breakthrough Technologies Designed to Meet the Rising Demand for Bandwidth Across AI-Driven Data Centers and Networks SANTA CLARA, Calif. – Sept. 20, 2024 Marvell Technology, Inc. (NASDAQ: MRVL), a leader in data infrastructure semiconductor solutions, will showcase its industry-leading optical technology designed to meet the rising performance demands of AI cloud data centers at…